FDA May Ask Circulatory Panel To Revisit AF Burden Definition, CryoCor Says

The CryoCor cardiac cryoablation system will be the first FDA-approved device for treating paroxysmal (episodic) atrial fibrillation by ablating the pulmonary vein ostia, the source of about one-third of all AF, according to San Diego developer CryoCor